Effects of Vildagliptine and Glimepiride on Glucose Variability

Summary

The purpose of this study is to analyze the differences of blood sugar level and glycemic variability between sulfonylurea and DPP-4 inhibitor groups applying CGMS for a chosen number of type 2 DM patients. The investigators also reveal influences of each drugs on cardiovascular risk factors by measuring related biomarkers.

Timeline

Start

2013-03

Primary completion

2015-08

Completion

2015-10

Drugs

Indications